• LAST PRICE
    0.6350
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0000 / 0.6350
  • Day Range
    ---
  • 52 Week Range
    Low 0.3250
    High 14.0020
  • Volume
    52
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table
TimeVolumeUTRS
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesUTRS
Minerva Surgical Inc
5.6M
-0.1x
---
United StatesSONX
Sonendo Inc
7.1M
-0.2x
---
United StatesDFCO
Dalrada Financial Corp
13.6M
-0.6x
---
United StatesBIOCQ
Biocept Inc
260.0
0.0x
---
United StatesTRIB
Trinity Biotech PLC
15.1M
-0.1x
---
United StatesINLB
Item 9 Labs Corp
25.6K
0.0x
---
As of 2024-03-28

Company Information

Minerva Surgical, Inc. is a commercial-stage medical technology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. It has established a product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of Abnormal Uterine Bleeding (AUB) in most uterine anatomies. Its Minerva Surgical solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies. It offers a range of solutions, such as the Minerva ES Endometrial Ablation System (Minerva ES), Genesys HTA Endometrial Ablation System (Genesys HTA), Symphion Tissue Removal System (Symphion), and Resectr Tissue Resection Device (Resectr). Minerva ES is an endometrial ablation device that utilizes its PlasmaSense technology.

Contact Information

Headquarters
101 Saginaw DriveREDWOOD CITY, CA, United States 94063
Phone
650-284-3500
Fax
302-655-5049

Executives

Non-Executive Chairman of the Board
Uri Geiger
President, Chief Executive Officer, Director
Todd Usen
Chief Financial Officer
Joel Jung
Chief Operating Officer
Dominique Filloux
Vice President of Medical Affairs
Evgueni Skalnyi

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$5.6M
Revenue (TTM)
$51.7M
Shares Outstanding
8.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-8.36
Book Value
$11.52
P/E Ratio
-0.1x
Price/Sales (TTM)
0.1
Price/Cash Flow (TTM)
---
Operating Margin
-56.60%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.